Val G. Ross

630 total citations
8 papers, 534 citations indexed

About

Val G. Ross is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Val G. Ross has authored 8 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Pathology and Forensic Medicine and 3 papers in Cancer Research. Recurrent topics in Val G. Ross's work include Cancer-related Molecular Pathways (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and HER2/EGFR in Cancer Research (2 papers). Val G. Ross is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and HER2/EGFR in Cancer Research (2 papers). Val G. Ross collaborates with scholars based in United Kingdom and India. Val G. Ross's co-authors include Judith McKay, Stephanie Curran, Howard L. McLeod, Graeme I. Murray, Jim Cassidy, Joseph Loane, G I Murray, Louise Murray, Caroline Clark and J Cassidy and has published in prestigious journals such as British Journal of Cancer, International Journal of Cancer and European Journal of Cancer.

In The Last Decade

Val G. Ross

8 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Val G. Ross United Kingdom 6 427 171 151 140 94 8 534
H.J. Lenz United States 9 366 0.9× 250 1.5× 78 0.5× 108 0.8× 91 1.0× 24 551
Domizia Debernardis Italy 11 577 1.4× 236 1.4× 131 0.9× 191 1.4× 88 0.9× 16 692
Amy E. Hanna United States 6 300 0.7× 307 1.8× 188 1.2× 43 0.3× 98 1.0× 6 533
Marja Hilska Finland 9 299 0.7× 166 1.0× 52 0.3× 79 0.6× 203 2.2× 11 476
Andrea Pretta Italy 12 272 0.6× 182 1.1× 102 0.7× 59 0.4× 139 1.5× 47 478
Y Uenoyama Japan 7 243 0.6× 221 1.3× 54 0.4× 84 0.6× 63 0.7× 8 509
Inna Khodos United States 9 364 0.9× 360 2.1× 198 1.3× 56 0.4× 106 1.1× 17 614
Helen Cawley United States 11 487 1.1× 366 2.1× 149 1.0× 96 0.7× 211 2.2× 16 812
Pina Ziranu Italy 12 251 0.6× 200 1.2× 116 0.8× 71 0.5× 143 1.5× 39 482
Sonia Garofalo Italy 6 189 0.4× 145 0.8× 126 0.8× 34 0.2× 50 0.5× 7 364

Countries citing papers authored by Val G. Ross

Since Specialization
Citations

This map shows the geographic impact of Val G. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Val G. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Val G. Ross more than expected).

Fields of papers citing papers by Val G. Ross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Val G. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Val G. Ross. The network helps show where Val G. Ross may publish in the future.

Co-authorship network of co-authors of Val G. Ross

This figure shows the co-authorship network connecting the top 25 collaborators of Val G. Ross. A scholar is included among the top collaborators of Val G. Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Val G. Ross. Val G. Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
McKay, Judith, Louise Murray, Stephanie Curran, et al.. (2002). Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases. European Journal of Cancer. 38(17). 2258–2264. 179 indexed citations
2.
McKay, Judith, Joseph Loane, Val G. Ross, et al.. (2002). c-erbB-2 is not a major factor in the development of colorectal cancer. British Journal of Cancer. 86(4). 568–573. 64 indexed citations
3.
McKay, Judith, Val G. Ross, Stephanie Curran, et al.. (2002). Analysis of key cell‐cycle checkpoint proteins in colorectal tumours. The Journal of Pathology. 196(4). 386–393. 75 indexed citations
4.
McKay, Judith, Patrick H. Rooney, Val G. Ross, et al.. (2001). Marked differences in tumour-associated protein expression and genetic stability between proximal and distal colon tumours. European Journal of Cancer. 37. S272–S272. 2 indexed citations
5.
Pritchard, Stuart C., M. Nicolson, Judith McKay, et al.. (2001). Expression of matrix metalloproteinases 1, 2, 9 and their tissue inhibitors in stage II non-small cell lung cancer: Implications for MMP inhibition therapy. Oncology Reports. 8(2). 421–4. 52 indexed citations
6.
Payne, Shay, et al.. (2000). Immunohistochemical detection of a germline BRCA1 mutation in a breast and ovarian cancer family. The Breast. 9(5). 286–291. 2 indexed citations
7.
McKay, Judith, et al.. (2000). Cyclin D1 protein expression and gene polymorphism in colorectal cancer. International Journal of Cancer. 88(1). 77–81. 110 indexed citations
8.
McKay, Judith, Jacinta Douglas, Val G. Ross, et al.. (2000). Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases.. PubMed. 6(3). 1113–8. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026